Want to join the conversation?
$OREX's wholly owned subsidiary Orexigen Therapeutics Ireland, Ltd. entered into a distributorship agreement for Contrave with Korea-based company Kwang Dong Pharmaceutical Company, Ltd. Kwang Dong expects to begin marketing Contrave in 2H16. For the nine months ended Sept. 30, 2015, $OREX recognized revenues under this agreement of $61,000.
Any idea why some investors are happy about the disastrous $UA results??
Wow! GM killed it with earnings today! Did not expect this after $F gave the feeling it will eclipse the Chevy maker completely!
Oil rebound starting to show up in energy stocks. $XOM $CVX
I have a feeling "CLOUDy" days are ahead, with $AMZN leading the pack.
$AAL is giving pay hikes to its employees but investors are sulking.